New Delhi: Dr Reddy’s Laboratories para aji 2-Deoxy-D-Glucose (2-DG) commercial jolaboli junaishe, etu para Covid bemar manuh ke elaj koribo aro tawai toh metros aro Tier 1 cities hospitals te paijaboli koishe. Etu tawai toh DRDO aro Dr Reddy’s Laboratories para bona ase aro etu para speed up recovery aro oxygen dependence komti koribo. Dr Reddy’s para tawai toh sachets te olaishe koikena khobor toh janaishe. “Dr Reddy’s para tangor government aro India laga desh pura private hospitals te paijaboli koishe. Company para etu tawai toh metros and Tier 1 cities hospitals te supply koribo aro India pura te expand korikena jabo,” koikena company para statement te janaishe. Etu tawai laga maximum daam toh Rs 990 ase aro government institutions te discounted rate te thiboli koishe. “2-DG toh oral drug ase aro etu tawai toh kali qualified physician laga prescription te COVID-19 bemar manuh nemite ase,” company para janaishe. Etu tawai toh May 1 darik te COVID-19 bemar manuh nemite emergency te joboli manishe. “2-DG toh aro dosura COVID-19 portfolio nemite addition ase aro full spectrum of mild moderate aro besi beya halat te vaccine samil ase. Ami khan kushi ase ke DRDO logot melikena COVID-19 bemari samai larai koribo,” koikena Satish Reddy, Chairman, Dr Reddy para khobot toh janaishe.
Dr Reddy para Covid Drug 2-DG commercial olaishe
Add Comment